AngioDynamics Current Liabilities vs. Market Capitalization

ANGO Stock  USD 5.87  0.16  2.65%   
Based on AngioDynamics' profitability indicators, AngioDynamics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in May. Profitability indicators assess AngioDynamics' ability to earn profits and add value for shareholders. At this time, AngioDynamics' Days Sales Outstanding is very stable compared to the past year. As of the 25th of April 2024, EV To Sales is likely to grow to 2.49, while Price To Sales Ratio is likely to drop 1.20. At this time, AngioDynamics' Change To Netincome is very stable compared to the past year. As of the 25th of April 2024, Net Income Per E B T is likely to grow to 0.95, though Accumulated Other Comprehensive Income is likely to grow to (5.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.590.5144
Fairly Up
Slightly volatile
For AngioDynamics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AngioDynamics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AngioDynamics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AngioDynamics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AngioDynamics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.80)
Revenue Per Share
8.105
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.05)
Return On Equity
(0.62)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AngioDynamics Market Capitalization vs. Current Liabilities Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth.
AngioDynamics is rated fifth in current liabilities category among related companies. It is rated below average in market capitalization category among related companies creating about  3.62  of Market Capitalization per Current Liabilities. At this time, AngioDynamics' Market Cap is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value AngioDynamics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AngioDynamics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.

AngioDynamics Market Capitalization vs. Current Liabilities

Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

AngioDynamics

Current Liabilities

 = 

Payables

+

Accrued Debt

 = 
66.73 M
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

AngioDynamics

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
241.53 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

AngioDynamics Market Capitalization vs Competition

AngioDynamics is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 44.35 Billion. AngioDynamics maintains roughly 241.53 Million in market capitalization contributing less than 1% to equities under Health Care industry.
Capitalization  Valuation  Revenue  Workforce  Total debt

AngioDynamics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in AngioDynamics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AngioDynamics will eventually generate negative long term returns. The profitability progress is the general direction of AngioDynamics' change in net profit over the period of time. It can combine multiple indicators of AngioDynamics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5.4 M-5.2 M
Operating Income-17.3 M-16.4 M
Income Before Tax-49 M-46.5 M
Total Other Income Expense Net-31.7 M-30.1 M
Net Loss-47.2 M-44.8 M
Income Tax Expense-1.8 M-1.7 M
Net Loss-47.2 M-44.8 M
Net Loss-47.2 M-44.8 M
Non Operating Income Net Other-637.1 K-669 K
Net Interest Income-3.1 M-3.3 M
Interest Income816.3 K775.5 K
Change To Netincome32.8 M34.4 M
Net Loss(1.53)(1.45)
Income Quality(0)(0)
Net Income Per E B T 0.87  0.95 

AngioDynamics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on AngioDynamics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AngioDynamics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AngioDynamics' important profitability drivers and their relationship over time.

Use AngioDynamics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

AngioDynamics Pair Trading

AngioDynamics Pair Trading Analysis

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your AngioDynamics position

In addition to having AngioDynamics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out Trending Equities.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
To fully project AngioDynamics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AngioDynamics' income statement, its balance sheet, and the statement of cash flows.
Potential AngioDynamics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although AngioDynamics investors may work on each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.